HKD 1.44
(6.67%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -116.11 Million CNY | 78.03% |
2022 | -528.47 Million CNY | -283.79% |
2021 | 287.54 Million CNY | 174.32% |
2020 | -386.88 Million CNY | -245.51% |
2019 | 265.87 Million CNY | 193.62% |
2018 | 90.55 Million CNY | 18.74% |
2017 | 76.26 Million CNY | 211.61% |
2016 | 24.47 Million CNY | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 116.8 Million CNY | 0.0% |
2023 FY | -116.11 Million CNY | 78.03% |
2023 Q2 | 1.01 Million CNY | 0.0% |
2023 Q4 | -117.12 Million CNY | 0.0% |
2022 Q2 | -91.2 Million CNY | 0.0% |
2022 FY | -528.47 Million CNY | -283.79% |
2022 Q4 | -437.27 Million CNY | 0.0% |
2021 Q4 | 202.52 Million CNY | 0.0% |
2021 FY | 287.54 Million CNY | 174.32% |
2021 Q2 | 85.02 Million CNY | 0.0% |
2020 Q4 | 143.39 Million CNY | 0.0% |
2020 FY | -386.88 Million CNY | -245.51% |
2020 Q2 | -530.27 Million CNY | 0.0% |
2019 Q4 | 219.37 Million CNY | 0.0% |
2019 Q2 | 46.49 Million CNY | 0.0% |
2019 FY | 265.87 Million CNY | 193.62% |
2018 Q4 | 39.74 Million CNY | 0.0% |
2018 FY | 90.55 Million CNY | 18.74% |
2018 Q2 | 50.8 Million CNY | 0.0% |
2017 Q1 | 19.06 Million CNY | 0.0% |
2017 FY | 76.26 Million CNY | 211.61% |
2017 Q4 | 22.63 Million CNY | 0.0% |
2017 Q2 | 19.06 Million CNY | 0.0% |
2016 Q4 | 19.06 Million CNY | 0.0% |
2016 Q1 | 6.11 Million CNY | 0.0% |
2016 FY | 24.47 Million CNY | 0.0% |
2016 Q2 | 6.11 Million CNY | 0.0% |
2015 Q4 | 6.11 Million CNY | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Uni-Bio Science Group Limited | 70.87 Million HKD | 263.826% |
CK Life Sciences Int'l., (Holdings) Inc. | 17.25 Million HKD | 773.119% |